908 Devices Inc. (NASDAQ:MASS) Shares Acquired by 49 Wealth Management LLC

49 Wealth Management LLC grew its holdings in 908 Devices Inc. (NASDAQ:MASS) by 16.2% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 31,099 shares of the company’s stock after buying an additional 4,343 shares during the quarter. 49 Wealth Management LLC’s holdings in 908 Devices were worth $108,000 at the end of the most recent quarter.

Several other hedge funds have also modified their holdings of the business. Charles Schwab Investment Management Inc. raised its holdings in 908 Devices by 14.6% during the third quarter. Charles Schwab Investment Management Inc. now owns 220,477 shares of the company’s stock worth $765,000 after purchasing an additional 28,015 shares during the last quarter. Connor Clark & Lunn Investment Management Ltd. acquired a new position in shares of 908 Devices in the third quarter worth $190,000. Drive Wealth Management LLC acquired a new position in shares of 908 Devices in the third quarter worth $50,000. SG Americas Securities LLC acquired a new position in shares of 908 Devices in the third quarter worth $36,000. Finally, Cubist Systematic Strategies LLC acquired a new position in shares of 908 Devices in the second quarter worth $311,000. 88.06% of the stock is owned by institutional investors and hedge funds.

908 Devices Stock Down 6.6 %

Shares of NASDAQ MASS opened at $2.56 on Friday. 908 Devices Inc. has a 1-year low of $2.19 and a 1-year high of $12.51. The business has a 50-day moving average of $3.32 and a 200-day moving average of $4.55.

Wall Street Analyst Weigh In

A number of equities analysts have recently weighed in on the company. Stifel Nicolaus cut their price target on 908 Devices from $17.00 to $6.00 and set a “buy” rating for the company in a report on Wednesday, November 13th. Leerink Partners reaffirmed a “market perform” rating and issued a $4.00 price objective (down previously from $12.00) on shares of 908 Devices in a research report on Wednesday, November 13th. Finally, Leerink Partnrs downgraded 908 Devices from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, November 13th.

908 Devices Company Profile

908 Devices Inc, a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, pharma/biopharma, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and Maverick, an optical in-line analyzer that offers real-time monitoring and control of multiple bioprocess parameters, including glucose, lactate, and total biomass in mammalian cell cultures, as well as provides process fingerprint data to support large-scale efforts in predictive bioprocess modeling.